Top news
Continuing to Follow the Science: An Open Letter from Pfizer Chairman and CEO Dr. Albert Bourla
Gottlieb says Biden administration "in a better position" for booster rollout but worries vaccine mandate will harden skeptics
By Shani Benezra
FDA advisory group rejects Covid boosters for most, limits to high-risk groups
All coverage
Covid-19: How effective is a third vaccine dose?
By Zaria Gorvett
New Study of Covid Booster Shots Fans Debate Over Benefits (Published 2021)
By Apoorva Mandavilli
FDA panel votes against Pfizer's Covid-19 booster jab application
By Jamie Smyth, Nikou Asgari & Kiran Stacey
Moderna says COVID-19 vaccine protection wanes, makes case for booster
By Julie Steenhuysen
FDA advisory panel rejects widespread Pfizer vaccine booster shots
By Lauran Neergaard & Matthew Perrone
Moderna's vaccine is the most effective, but Pfizer and J&J also protect well, CDC-led study says
By Maggie Fox
FDA panel recommends Pfizer's Covid booster doses for people 65 and older after rejecting third shots for general population
By Berkeley Lovelace, Robert Towey & Berkeley Lovelace Jr.